EP
Eversept Partners Portfolio holdings
AUM
$992M
This Quarter Return
+26.68%
1 Year Return
+2.54%
3 Year Return
+103.47%
5 Year Return
+181.01%
10 Year Return
–
AUM
$1.34B
AUM Growth
+$1.34B
(+31%)
Cap. Flow
+$82.2M
Cap. Flow
% of AUM
6.14%
Top 10 Holdings %
Top 10 Hldgs %
62.68%
Holding
74
New
17
Increased
20
Reduced
29
Closed
4
Top Buys
| 1 |
GSK
GSK
|
$34.3M |
| 2 |
Revvity
RVTY
|
$31.5M |
| 3 |
Pfizer
PFE
|
$30.6M |
| 4 |
Viatris
VTRS
|
$15.7M |
| 5 |
Inspire Medical Systems
INSP
|
$14.9M |
Top Sells
| 1 |
Natera
NTRA
|
$43.3M |
| 2 |
IMGN
Immunogen Inc
IMGN
|
$22.2M |
| 3 |
argenx
ARGX
|
$12.3M |
| 4 |
Illumina
ILMN
|
$12.1M |
| 5 |
Krystal Biotech
KRYS
|
$11.1M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
51
Krystal Biotech
KRYS
$4.35B
| $3.3M | 0.22% |
18,557
-62,241
| -77% | -$11.1M |
|
52
Alector
ALEC
$282M
| $3.23M | 0.22% |
+536,171
| New | +$3.23M |
|
53
Avantor
AVTR
$8.74B
| $3.21M | 0.21% |
125,394
-570
| -0.5% | -$14.6K |
|
54
IQVIA
IQV
$31.4B
| $3.08M | 0.21% |
12,178
-85
| -0.7% | -$21.5K |
|
|
MOR
55
DELISTED
MorphoSys AG American Depositary Shares
MOR
| $3.01M | 0.2% |
+165,924
| New | +$3.01M |
|
56
Viridian Therapeutics
VRDN
$1.59B
| $2.49M | 0.17% |
142,075
+4,732
| +3% | +$82.9K |
|
57
Molina Healthcare
MOH
$9.6B
| $2.39M | 0.16% |
5,828
-289
| -5% | -$119K |
|
58
Xoma
XOMA
$421M
| $2.33M | 0.16% |
97,065
+3,338
| +4% | +$80.3K |
|
59
InflaRx
IFRX
$117M
| $2.01M | 0.13% |
1,305,140
| – | – |
|
60
Viking Therapeutics
VKTX
$3.02B
| $1.87M | 0.12% |
+22,818
| New | +$1.87M |
|
61
Terns Pharmaceuticals
TERN
$651M
| $1.86M | 0.12% |
+283,034
| New | +$1.86M |
|
|
JBIO
62
Jade Biosciences, Inc. Common Stock
JBIO
$245M
| $1.6M | 0.11% |
54,150
+3,908
| +8% | +$116K |
|
63
CureVac
CVAC
$1.21B
| $1.56M | 0.1% |
515,691
+18,779
| +4% | +$56.9K |
|
64
Repligen
RGEN
$6.54B
| $1.51M | 0.1% |
8,237
-1,747
| -17% | -$321K |
|
65
Seres Therapeutics
MCRB
$162M
| $1.08M | 0.07% |
1,388,944
-364,594
| -21% | -$282K |
|
|
AFMD
66
DELISTED
Affimed
AFMD
| $882K | 0.06% |
166,460
-1,510,224
| -90% | -$6.4K |
|
|
VINC
67
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
| $403K | 0.03% |
+79,588
| New | +$403K |
|
68
AC Immune
ACIU
$227M
| $369K | 0.02% |
124,589
| – | – |
|
|
IMGN
69
DELISTED
Immunogen Inc
IMGN
| – | – |
-748,950
| Closed | -$22.2M |
|
70
SPDR S&P 500 ETF Trust
SPY
$656B
| – | – |
0
| – | – |
|
71
Invesco QQQ Trust
QQQ
$364B
| – | – |
0
| – | – |
|
|
72
Illumina
ILMN
$15.2B
| – | – |
-86,614
| Closed | -$12.1M |
|
73
Biohaven
BHVN
$1.71B
| – | – |
-66,898
| Closed | -$2.86M |
|
74
Agilent Technologies
A
$35.5B
| – | – |
-37,854
| Closed | -$5.26M |
|